PROF News

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Profound Medical Corp. Announces Closing of Private Placement

Profound Medical Corp. Announces Upsize of Private Placement

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation

Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease